Research progress of hepatocellular carcioma patient-derived human tumor xenograft models / 中国药理学通报
Chinese Pharmacological Bulletin
;
(12): 475-478, 2020.
Article
Dans Chinois
| WPRIM
| ID: wpr-856987
ABSTRACT
Patient-derived human tumor xenograft (PDX) models can maintain the histopathological, growth and metastasis characteristics of primary tumors well, and can still retain these characteristics of primary tumors in large degreeafter multiple passages. It is closely related to the tumors of primary patients with great importance in scientific research. The hepatocellular carcinoma PDX models has been used in patients'individualized drug screening, evaluation of drug efficacy, exploration of treatment direction, occurrence and development mechanism of hepatocellular carcinoma, etc. It shows excellent application prospects. This article reviews the methods, applications and tumorigenie factors of hepatocellular carcinoma PDX model.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Étude pronostique
langue:
Chinois
Texte intégral:
Chinese Pharmacological Bulletin
Année:
2020
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS